Stock prices in London opened in the green on Friday, with investors confident of a softer US jobs report, which take some sting out of hawkish Federal Reserve interest rate expectations.The FTSE 100 index rose 20.31 points, 0.2%, at 8,192.46. The FTSE 250 edged up 14.81 points, 0.1%, to 20,067.14, and the AIM All-Share rose 1.54 points, 0.2%, at 769.65.The Cboe UK 100 was up 0.2% at 818.09, the C

- Company raises £20.13 million at 14.4% discount- Funds will accelerate multiple pathways to commercialisation, claims company- Hopes to exploit first mover advantageLiquid biopsy company ANGLE (AGL:AIM) has raised £20.13 million in gross proceeds following a successful placing of new shares at 80p per share, with a retail investor offer included.Chief executive Andrew Newland and chief financi

- Group acquires Mexican style fast-casual chain Barburrito- Like-for-like sales up 20% year-to-date- Accelerates growth opportunityWagamama owner Restaurant Group (RTN) has acquired award-winning Mexican style fast-casual restaurant chain Barburrito for £7 million and made an early repayment of £44 million of loan facilities.The Mexican-themed business operates across 16 sites in high footfall

- Company secures follow-up contract worth up to $1.2 million- Ongoing discussions with multiple potential new customers- First mover advantage in attractive liquid biopsy marketBiopsy technology company Angle (AGL:AIM) has won a follow-up contract with its first large scale pharma services customer it announced in April 2021, proving it can generate repeat business from large pharma companies.The

After six long years of gathering data and evidence ANGLE's (AGL:AIM) liquid biopsy platform Parsortix was given regulatory approval from the US Federal Drug Administration for use in the detection of metastatic breast cancer.Although it has been a long wait for investors FDA approval is a significant milestone for ANGLE and has the potential to unlock a multi-billion market opportunity.FDA approv

We might have thought we'd seen it all after 2020 but it's been quite a year in 2021 too with an impressive rebound for the markets from the ravages of the pandemic.But which stocks have done best? Read on to discover the top performers up and down the market cap spectrum and find out why they've done so well. For the purposes of this article we've deliberately excluded investment trusts.£4 billi

The FTSE closed higher on Friday reaching its highest level since October 2019 as a raft of positive economic data was released in the US and China.US new homes increased 19.4% in March, the biggest monthly gain since 2006 during the housing bubble. The University of Michigan consumer confidence was higher showing increasing consumer confidence, although the reading of 86.5 was below economists' f

London's FTSE 100 added to gains at midday Friday as investors cheered signs that the global recovery remains on track following data showing China's economy grew at record pace in the first quarter.FTSE 100 miners and oil producers were in demand after China reported year-on-year GDP growth of 18.3% in the first quarter of 2021, giving investors greater optimism in terms of the outlook for global

Shares in biopsy technology company Angle (AGL:AIM) surged 6.4% to 88.5p on Friday after the company announced its first big pharma services contract.The contract is the first large-scale adoption of the company's Parsortix cell separation system, which isolates circulating tumour cells from a patient's blood.The company claims that looking for tumour cells in liquid blood has advantages over tiss

London's FTSE 100 was back above the 7,000 level for the first time since February 2020 on Friday as investors cheered signs that the global recovery remains on track following data showing China's economy grew at record pace in the first quarter.By 8.45 am, the blue chip benchmark was up 32.3 points or 0.46% at 7,015.75, representing a massive milestone in recovering from the terrible pandemic an

The FTSE 100 posts a modest gain of 2.4 points to 7,322.07 as a breakthrough has been made on Brexit negotiations. Overnight the European Commission decided that enough progress had been made to allow trade negotiations to begin. The market will also closely be watching the monthly industrial production figures due out today.Amid corporate news, housebuilder Berkeley (BKG) gains 5.1% to £40.42 af

Pharma giant GlaxoSmithKline's (GSK) drug Juluca should help to drive value in its HIV-focused ViiV business after being approved by the US Food & Drug Administration (FDA).HIV is a virus that damages cells in the immune system, making it more difficult for people to fight off infections and disease.Market is 'undervaluing' hiv businessJuluca is the first treatment for HIV-1 that contains just two

Cancer technology company Angle (AGL:AIM) has taken another step towards commercialising its cell separation technology called Parsortix. Latest test data shows the system is capable of detecting if some cancercous masses are malignant or benign from a simple blood test.The clinical trials assessed pelvic masses shown up in 400 patients. The Parsortix system was able to tell the difference between

The UK stock market gets off to a slow start in early trade on Tuesday with most market watchers predicting that the FTSE 100 will pare some of the gains made on Monday. The UK blue chip index closed 0.9% higher at 7,377.09 points yesterday, bolstered by strong gains among financials, miners and energy companies as oil prices firmed.Early deals show the FTSE 100 off by around 30 points at 7,345.Br

The FTSE 100 falls 0.6% to 7,429, dragged down by weakness in mining and utility stocks.Sofa maker DFS (DFS) falls 22.3% to 197.75p after issuing a profit warning. The company says the trading environment has weakened beyond its expectations and that it has seen significant declines in footfall in its shops.That news prompts a sell-off in other retail stocks, particularly those with larger ticket

The FTSE 100 is a handful of points higher at 7,552.83 as trading resumes after the terrorist attack at London Bridge over the weekend.Online groceries firm Ocado (OCDO) gains 6.6% to 336.8p as it flags the first international customer for its Ocado Smart Platform. The regional European retailer - which wishes to remain anonymous - will pay an up-front fee along with ongoing charges based on the v

In November 2011 the FTSE had just broken through 6,200 and the Bank of England's key interest rates was 5% and rising. Could the FTSE 100 rise through the 7,000 mark by 2007, Shares asked? 'As long as the Bank of England doesn't keep tightening the screws, we should be OK', we said. A year later rates were 5.75% and the FTSE did not hit 7,000 until early 2015. Key picks in that edition included E

In early dealings on Tuesday, the FTSE 100 drifts 25.36 points lower to 6,670 and the FTSE 250 is off 58.5 points at 16,809, London's indices tracking some mixed perfomances overnight from global markets as well as weaker oil prices.Leading mining stocks are among the notable fallers, with Rio Tinto (RIO) down 2.2% to £24.07 as second quarter production figures confirm a surge in iron ore output.

News that the NHS is to pay for a combination of drugs that have proved effective at treating skin cancer is a sign that the healthcare market is turning to immunotherapy to fight cancer.This has positive implications to investors in stocks such as AstraZeneca (AZN), Horizon Discovery (HZD:AIM) and SalvaRx (SALV:AIM).The announcement by the NHS follows a breakthrough in May in medical sciences' un

Investors showed their appetite for cancer diagnostic developer Angle (AGL:AIM) on Wednesday by supporting a substantial share placing at a zero discount. The Guildford-based company, which has developed a liquid biopsy device to detect cancer, raised £10.2 million, more than a quarter of its market cap, by selling around 15.8 million shares at 64.5p each, bang on Tuesday's closing price.Supporte